Cover Image


Closed Drug Transfer Systems to 2022

出版商 Greystone Research Associates 商品編碼 135878
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
封閉式藥物轉移系統 Closed Drug Transfer Systems to 2022
出版日期: 2016年12月12日 內容資訊: 英文





  • 治療趨勢與問題點
  • 注射型/點滴型抗癌藥物的施給
  • 醫藥品包裝和給藥技術
  • 封閉式藥物轉移市場推動因素
  • 競爭情形
  • 危險因素


  • 主要的系統設計因素
  • 人因工程/人體工學
  • 物質選擇的問題點
  • 藥物的重組與稀釋
  • 癌症治療藥的安全性
  • 癌症治療藥的給藥和用量
  • 各藥物的用量設定和個人的用量設定

封閉式藥物轉移 - 商用設備的評估與市場資料

  • ChemoCLAVE
  • EquaShield
  • OnGuard
  • PhaSeal
  • Texium/SmartSite
  • 其他封閉式藥物轉移設備


  • 法規上的問題點
  • 看護者的適合性
  • 複雜的層級與易用性
  • 醫療經濟
  • 經營模式與策略


  • 北美
  • 歐洲
  • 亞洲
  • 其他地區市場

封閉式藥物轉移 - 市場參與企業簡介


Product Code: DTS555F

The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. Studies of nurses who work with cytotoxic drugs on a regular basis have found a statistically higher rate of spontaneous abortion. Several companies are responding to this unmet need by commercializing devices for closed transfer of these drugs. As the market evolves and user acceptance increases, so too will the impact of these products on oncology therapy protocols and drug delivery


  • Analyzes the impact of drug toxicity and safety factors on therapeutic oncology market segments, market dynamics and market demographics
  • Provides detailed analysis of closed drug transfer products for the handing of cytotoxic drugs
  • Analyzes demand drivers and competitive factors influencing closed drug transfer adoption
  • Charts product data and provides forecasts to 2022
  • Profiles closed drug transfer device participants, their product development activities, business strategies, and corporate alliances and affiliations

Table of Contents

Summary of Contents

Executive Summary

Cytotoxic Drug Therapeutics Market Dynamics

Therapeutic Trends and Issues

  • The Administration of injectable/Infusible Antineoplastics
  • Drug Packaging and Administration Technology
  • Closed Drug Transfer Market Drivers
  • Competitive Landscape
  • Risk Factors
  • Closed Drug Transfer Design Factors

Key System Design Elements

  • Human Engineering/Ergonomics
  • Material Selection Issues
  • Drug Reconstitution and Dilution
  • Oncology Therapeutics Medication Safety
  • Oncology Drug Administration and Dosing
  • Drug-Specific Dosing Modification and Individualized Dosing

Closed Drug Transfer - Commercial Device Assessments

Market Factors

Regulatory Issues

  • Caregiver Compliance
  • Level of Complexity and Ease of Use
  • Healthcare Economics
  • Business Models and Strategies

Market Assessments and Forecasts

North America

  • Europe
  • Asia
  • Other Geographic Markets

Closed Drug Transfer - Market Participant Profiles

Back to Top